CDER's Office of Prescription Drug Promotion sends an untitled letter to Edenbridge Pharmaceuticals over Hemady promotional materials used at a medica...
FDA accepts for review a Corcept Therapeutics NDA for relacorilant and its use in treating patients with endogenous hypercortisolism (Cushings syndrom...
Protagonist Therapeutics and Takeda report positive topline results for the Phase 3 VERIFY study that is evaluating rusfertide for treating polycythem...
Lexicon Pharmaceuticals says it will advance pain drug pilavapadin 10mg into a planned Phase 3 trial based on just-announced Phase 2 PROGRESS study re...
PharmaTher also said it was working with its third-party manufacturing partner to resolve the deficiencies.
Boston Scientific recalls its Accolade pacemakers and Visionist and Valitude cardiac resynchronization therapy pacemakers due to the possibility of th...
Philips recalls its Tack Endovascular Systems due to customer complaints, including events where additional interventions were required to retrieve or...
Pharmaceutical Research and Manufacturers of America says FDA should make sure its recent draft guidance entitled Protocol Deviations for Clinical Inv...
